Market Tracker

10/22 7:56am ET

NewLink Genetics Corp (NASDAQ:NLNK)

Tuesday’s Trading Day
34.50 +3.06 / +9.73%
Data as of Oct 21
Day’s Change
Wednesday’s Pre-Market   Switch to standard view »
34.70 +0.20 / +0.58%
 
Volume: 5.7K

Today’s Trading

Previous close31.44
Today’s open33.01
Day’s range-- - --
Volume2,262,184
Average volume (3 months)767,728
Market cap$877.5M
Dividend yield--
Data as of 10/21/2014

Growth & Valuation

Earnings growth (last year)-9.82%
Earnings growth (this year)-23.25%
Earnings growth (next 5 years)--
Revenue growth (last year)-35.21%
P/E ratioNM
Price/Sales508.97
Price/Book14.32

Competitors

 Today’s
change
Today’s
% change
ENTAEnanta Pharmaceutica...-4.76-10.22%
SAGESAGE Therapeutics In...+3.23+9.26%
MACKMerrimack Pharmaceut...0.000.00%
ARNAArena Pharmaceutical...-0.01-0.24%
Data as of 10/21/2014

Financials

Next reporting dateOctober 29, 2014
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$1.1M
Annual profit (last year)-$31.2M
Net profit margin-2,852.70%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts